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Abstract 
The MAP kinase module (Raf/MAPKKK-MAPKK-MAPK) has been shown to be sequentially activated after mitogenic stimulation. Here we 
demonstrate, bysite directed mutagenesis, that MAPK is able to retrophosphorylate its own activator, MAPKK, on two threoulne residues Thr-292 
and Thr-386 in vitro, and that these sites are also phnsphnrylated in vivo. A comparison of the kinetics of serum-mediated activation of a wild-type 
MAPKK and of a mutant unable to undergo phosphorylation by MAPK suggests that this retrophosphorylation may be involved in a negative 
feedback control of the cascade in vivo. 
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1. Introduction 2. Materials and methods 
Upon stimulation by a variety of growth factors, the 
protein kinases, Raf and MAP kinase kinase kinase 
(MAPKKK), MAP kinase kinase (MAPKK) and MAP 
kinase (MAPK), are successively activated by phospho- 
rylation (for a review see [1]). Activation of this kinase 
cascade, referred to as the 'MAP kinase module', ap- 
pears to be crucial for cell proliferation [2] and is proba- 
bly subject o tight regulation. Since protein kinases are 
involved in activation, it is assumed that protein 
phosphatases play a role in switching off this cascade. 
For instance, MKP-1, a phosphatase able to specifically 
dephosphorylate and inactivate MAPK, has recently 
been identified [3]. However, this does not rule out the 
possibility of other means of control. Indeed it has re- 
cently been described that cAPK was able to inhibit the 
activation of the MAPK module by phosphorylating Raf 
[4]. Furthermore, the protein kinase p34 cac2 has been 
shown to inhibit MAPK in vitro [5]. Finally MAPK is 
able to phosphorylate many upstream components of 
this cascade, such as the EGF receptor [6], the Ras nucle- 
otide exchange factor Sos [7], Raf [8], and even its own 
activator MAPKK [9]. However, it remains to be demon- 
strated that this phosphorylation is of physiological rele- 
vance and to determine whether it is involved in the 
regulation of the MAPK module. 
Here we show that MAPK phosphorylates MAPKK 
both in vitro and in vivo on two threonine residues, and 
that this retrophosphorylation may contribute to a feed- 
back control mechanism. 
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2.1. Materials 
[~-32p]ATP and the enhanced chemoluminescenee (ECL) immunode- 
tection system were from Amersham. The monoclonal antibody 
12CA5, raised against a peptide from Influenza HAl protein [10], was 
purchased from Babco (Emeryville, CA). 
2.2. Mutants of MAPKK 
MAPKK Chinese hamster cDNA was subeloned into the expression 
vector HA-pECE between the EcoRI sites, in frame with the bemag- 
glutinin epitope ll 1] as was previously performed for MAPK [12]. 
Single mutants T292A and T386 were obtained irectly in the HA- 
pECE expression vector by site-directed mutagenesis of double- 
stranded DNA according to the Clontech strategy [13]. The double 
mutant T292A/386A was constructed by exchanging the AccI/XbaI 
cassette of T292A by that of T386A. Fig. 1 illustrates the positions of 
the mutated forms of MAPKK used in this study. 
2.3. Cell culture 
The established Chinese hamster lung fibroblast line CCL39 (Amer- 
ican Type Culture Collection), its derivative PS 120, which lacks Na+/H + 
antiporter (NHEI) activity [14], and corresponding transfected cells 
were cultivated in Dulbecco's modified Eagle's medium (DMEM; 
Gibeo/BRL) containing 7.5% fetal calf serum, penicillin (50 U/ml) and 
streptomycin sulphate (50/zg/ml). Growth-arrested cells were obtained 
by serum deprivation for 16-24 h. 
2.4. Stable transfection 
We used NHE1 as a selective marker and the H+-kilhng selection 
technique as previously described [2]. PS120 cells (106 cells per 10 cm 
plate) were co-transfected by the calcium phosphate technique with 2 
/zg of pEAP expression vector (NHE1 cDNA) [15] and 20 gg of pECE 
expression vector containing different constructs of MAPKK. 48 h 
after transfection, cells were subjected to an acid-load selection that 
killed non-transfected cells, usually 90-95% of the cell population. Two 
additional acid-load selections were applied usually at days 4 and 8 after 
transfection. Stable clones were either selected for analysis or mixed to 
provide the transfected population. The population or individal clones 
were passaged with application of the acid-load selection once a week. 
2.5. Immune complex kinase assays 
2.5.1. Phosphorylation of MAPKK by MAPK. Quiescent CCL39 
ceils expressing the p44 isoform of MAPK tagged with the hemag- 
glutinin epitop¢ (HA-MAPK) were stimulated in HEPES-buffered 
DMEM with 20% serum for 5 minat 37°C. Cells were washed with 
ice-cold phosphate-buffered saline (PBS) and lysed in Triton lysis buffer 
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(50 mM Tris-HC1, pH 7.5, 100 mM NaC1, 50 mM NaF, 5 mM EDTA, 
40 mM fl-glycerophosphate, 200gM Na-orthovanadate, 0.1mM phen- 
ylmethyl-sulfonyl fluoride, 10 mM p-nitrophenyl phosphate, 4 gg/ml 
aprotinin, 1% Triton X-100) for 15 min at 4°C. Insoluble material was 
removed by centrifugation at 12,000 x g for 5 min at 4°C. Cell lysates 
were incubated with the 12CA5 antibody pre-adsorbed to protein A-  
Sepharose coated beads for 2 h at 4°C. The same procedure was fol- 
lowed for preparing the substrate, MAPKK tagged with the hemag- 
glutinin epitope (HA-MAPKK, WT or mutant) from non-stimulated 
PS120 ceils. Immune complexes were washed three times with Triton 
lysis buffer and the beads with the HA-MAPK and HA-MAPKK 
immune complexes were mixed and washed once with kinase buffer (20 
mM HEPES, pH 7.4, 20 mM MgC12, I mM MnCI2, 1 mM dithiotreitol, 
10 mM p-nitrophenylphosphate). MAPKK phosphorylation was as- 
sayed by resuspending the pellet in 50/tl of kinase buffer containing 50 
/tM of [?'-~2p]ATP (5,000 cpndpmoi). The reaction mixture was incu- 
bated for 30 min at 300C. The samples were heated at 95°C for 5 min 
and proteins eparated by SDS-PAGE (10% gels) [16]. The gel was then 
dried and subjected to autoradiography. 
2.5.2. MAPKK activity. Quiescent PS120 cells expressing differ- 
ent isoforms of HA-MAPKK were stimulated for the indicated times 
(1 min to 3 h) with 20% serum. Immunoprecipitation was performed 
as described above. The substrate, HA-MAPK, was immunoprecipi- 
tated from resting CCL39 cells as described above. Beads containing 
HA-MAPKK and HA-MAPK were mixed and kinase assays was per- 
formed as decribed above. 
2.6. In vivo phosphorylation 
Quiescent ceils in 10 cm plates were labelled for 12 h at 37°C in 
phosphate-free DMEM medium containing 500 gCi/ml [32p]ortho- 
phosphate. Ceils were stimulated by addition of 20% serum for 15 min 
at 37°C, washed with cold PBS and lysed in lysis buffer. After centrif- 
ugation at 12,000 x g for 5 rain at 4°C, the lysates were pre-cleared for 
1 h at 4°C with preimmune rabbit serum and 1 h with preimmune 
mouse serum pre-adsorbed on protein A-Sepharose. The lysates were 
then incubated for 2 h at 4°C with the 12CA5 antibody pre-adsorbed 
on protein A-Sepharose. Immune complexes were washed four times 
with Triton lysis buffer, twice with lysis buffer without NaC1, twice with 
lysis buffer containing 0.5 M LiCI and an additional two times with 
normal ysis buffer. Beads were then resuspended in Laemmli sample 
buffer, heated at 95°C for 5 min and the proteins were separated by 
SDS-PAGE (10% gels). The resolved proteins were then transferred to 
nitrocellulose (Hybond C, Amersham) and the membrane subjected to 
autoradiography for 30 min. The labelled proteins were then digested 
with trypsin (Sigma) and the tryptic phosphopeptides separated on 
phosphocellulose plates as previously described [17]. 
3. Results 
3.1. MAPK is able to phosphorylate its activator 
MAPKK 
In  order  to invest igate whether  MAPKK is indeed a 
target  for  MAPK phosphory la t ion ,  we stably expressed 
in f ibroblasts ei ther the p44 i so form o f  MAPK or  a fo rm 
o f  MAPKK,  both  tagged with the hemagg lut in in  ep i tope 
(HA-MAPK or  HA-MAPKK) .  Fig. 2A  shows that  HA-  
MAPK immunoprec ip i ta ted  f rom st imulated cells wi th  
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Fig. 2. Retrophosphorylation of MAPKK by MAPK PS120 cells were 
stably transfected with the vector alone (control), the wild-type form 
of MAPKK (WT) tagged with the hemagglutinin epitope (HA- 
MAPKK) and different MAPKK mutants (D208N, T292A, T386A 
and T292/386A). CCL39 cells expressing MAPK tagged with the 
hemagglutinin epitope (HA-MAPK) were arrested in Go and stimulated 
(+) or not (-) by 20% serum for 5 min. (A) HA-MAPK was im- 
munoprecipitated with the antibody directed against he HA epitope 
(anti-HA antibody) and its ability to phosphorylate MAPKK was as- 
sayed by incorporation of 32p on HA-MAPKK immunoprecipitated 
from quiescent cells with the anti-HA antibody. Different forms of 
HA-MAPKK were used as a substrate: WT or D208N mutant. (B) 
Mutants of the consensus sites of phosphorylation byMAPK were used 
as MAPK substrates: T292A, T386A and T292/386A. Note that the 
phosphorylation is reduced by 2 fold in single mutants when compared 
to the wild-type. (C) Levels of expression of the different isoforms of 
MAPKK were analysed by Western blot with the anti-HA antibody. 
the ant i -HA ant ibody  is able to phosphory la te  an inac- 
t ive HA-MAPKK immunoprec ip i ta ted  f rom quiescent  
cells wi th  the ant i -HA ant ibody  (lanes 3 and 4). This  
phosphory la t ion  is specific as it does not  occur  when 
D208N T292A T386 A 
NH 2 
P~TP 
(393) 
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Fig. 1. Schematic representation f the Chinese hamster MAP kinase kinase tagged with the hemagglutinin epitope (HA-MAPKK). The position 
of the mutations introduced and the kinases ubdomains VII, VIII, X and XI were indicated. 
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cells are transfected with the vector alone (Fig. 2A, lanes 
1 and 2). Secondly, it can not be attributed to auto- 
phosphorylation f MAPKK since an inactive mutant of 
MAPKK, mutated on the aspartic acid involved in phos- 
phate transfer (D208N) is phosphorylated by MAPK to 
the same extent as the wild-type MAPKK (Fig. 2A, lanes 
5 and 6). 
since Western blotting with the anti-HA antibody 
(Fig. 2C) revealed that the level of expression of the dif- 
ferent forms of HA-MAPKK was identical. These results 
indicate that both sites (Thr-292 and -386) of MAPKK 
are equally employed in vitro for MAPK phosphoryla- 
tion and that the phosphorylation f one site is independ- 
ent of the other. 
3.2. MAPKK is retrophosphorylated by MAPK on 
Thr-292 and-386 in vitro 
The peptidic sequence of the Chinese hamster 
MAPKK shows two putative consensus sites for MAPK 
phosphorylation (PXTP), Thr-292 and -386 (Fig. 1). 
Furthermore MAPKK has been shown to be 
phosphorylated mainly on threonine residues by MAPK 
[9]. Hence, we specifically mutated each threonine 
(T292A and T386A) individually or concommitantly 
(T292/386A) and stably expressed these mutants in fi- 
broblasts. To distinguish between these mutated forms 
of MAPKK and the endogenous wild-type form, we also 
tagged these mutants with the HA epitope. They were 
then analysed for their ability to be retrophosphorylated 
by MAPK in the same way as mentioned above. The 
single mutants T292A or T386A also undergo retro- 
phosphorylation by MAPK but this phosphorylation 
was decreased about 2 fold when compared to that of the 
wild-type MAPKK (Fig. 2A, lanes 2,3 and Fig. 2B, lanes 
1-4). In contrast, the double mutant T292/386A was no 
longer able to be phosphorylated by MAPK (Fig. 2B, 
lanes 5 and 6). This lack of phosphorylation was not due 
to a conformational change reducing the ability of the 
protein to be expressed, or to be immunoprecipitated 
3.3. Thr-292 and -386 are also phosphorylated in vivo 
To determine if these sites were also phosphorylated 
in vivo, we compared the phosphopeptide maps of the 
wild-type MAPKK and T292/386A mutant. Cells ex- 
pressing either the wild-type form of HA-MAPKK or the 
T292/386A mutant were arrested for 16 h in the presence 
of [32p]orthophosphate, then stimulated or not by 20% 
serum for 15 min. Immunoprecipitated HA-MAPKK 
(WT or T292/386A mutant) was subjected to digestion 
by trypsin, and phosphopeptides were resolved by two- 
dimensional nalysis (see section 2). The comparison be- 
tween the WT and T292/386A mutant of MAPKK, iso- 
lated from non-stimulated or stimulated cells, shows that 
the mutant lacks phosphopeptides 6 and 7 (Fig. 3). This 
result suggests that MAPKK is also phosphorylated in 
vivo on these two sites, probably by the endogenous 
MAP kinases. 
3.4. MAPKK retrophosphorylation by MAPK is involved 
in a negative feedback control 
To assess if this retrophosphorylation plays a role in 
MAPKK regulation, we compared the time-course of 
growth factor-stimulated MAPKK (WT vs. T292/386A 
mutant). Fig. 4 depicts the experiment comparing the 
serum 
WT 
- -  -t- 
l l ~ l l l l l  ~ ~ 
T292/386A 
Fig. 3. In vivo phosphorylation of wild-type HA-MAPKK or T292/386A mutant PS 120 coils expressing wild-type HA-MAPKK or T292/386A mutant 
were arrested inG O in the presence of[32p]orthophosphate and stimulated by20% serum for 15 rain. HA-MAPKK was immunoprecipitated with
the anti-HA antibody and blotted to a nitrocellulose membrane. Tryptic digestion was performed asdescribed in section 2and phosphopeptides w re 
resolved in two dimensions byelectrophoresis (horizontal xis) and by chromatography (vertical xis). The major phosphopeptides are numbered 
(1 to 9) and the origin of migration is shown by an arrow. Autoradiograms for WT MAPKK correspond to an overnight exposure whereas those 
for T292/386A correspond to3 days exposure. 
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Fig. 4. Comparison ftime-courses of activation ofwild-type MAPKK 
and T292/386A mutant. (A) Cells expressing HA-MAPKK (WT or 
T292/386A mutant) were arrested inGo and stimulated by 20% serum 
for the indicated times. HA-MAPKK was immunoprecipitated withthe 
antibody directed against the epitope, and its activity was assayed by 
its ability to phosphorylate th  epitope tagged form of MAPK (HA- 
MAPK) immunoprecipitated from resting cells with the anti-HA anti- 
body. Each time point was performed in duplicate and the autoradi- 
ogram shown is representative of three independent experiments. (B)
Relative MAPKK activities normalized tobasal levels. Quantification 
was obtained by densitometry scanning and computer analysis of the 
autoradiogram. 
WT and double mutant T292/386A MAPKK over a pe- 
riod of 3 h. Interestingly, this mutant exhibits higher 
kinase activity at an earlier time upon stimulation by 
serum growth factors (5 min) when compared to the 
wild-type form. After 3 h of stimulation by serum, a time 
at which retrophosphorylation s still evident, the kinase 
activity of the mutant decreases and approaches the wild- 
type activity (Fig. 4B). The same results were obtained 
with the single mutant T386A. These results support he 
notion that MAPK exerts a negative control on the cas- 
cade by retrophosphorylation of its activator MAPKK. 
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4. Discussion 
Here we show that the p44 isoform of MAPK, among 
many other targets, is able to phosphorylate MAPKK, 
an upstream component of the activation cascade, con- 
firming the results obtained by Matsuda et al. [9]. Mut- 
agenesis experiments demonstrate hat phosphorylation 
occurs both in vitro and in vivo on two threonine resi- 
dues (Thr-292 and -386) which share the consensus ite 
of phosphorylation by MAPK (PXTP). The observation 
that the WT MAPKK possesses the phosphopeptides 6 
and 7 (lacking in the T292/386A mutant), both under 
non-stimulated and stimulated conditions, may be ex- 
plained by a slow turnover of phosphate on these sites. 
Comparison of the in vivo activity of wild-type and the 
non-retrophosphorylatable form of MAPKK (T292/ 
386A) indicates that this retrophosphorylation s inhib- 
itory in the initial phase of activation by growth factors. 
This result is reminiscent of the situation observed in the 
yeast Saccharomyces cerevisiae, where the disruption of 
FUS3, the equivalent of MAPK, significantly enhances 
the activity of STE7, the homologue of mammalian 
MAPKK [18]. However the effect of phosphorylation f
MAPKK by MAPK, although reproducible, is not so 
striking. A more pronounced effect should be seen upon 
disruption of both p42 and p44 MAPK or over-expres- 
sion of a dominant negative mutant of MAPK. Interest- 
ingly the single mutant T386AJMAPKK, in common 
with the double mutant, displays an increased activity 
upon short-term stimulation by serum (data not shown). 
This result suggests that phosphorylation of Thr-386, a 
residue which is conserved in MAPKK from all the spe- 
cies tested, seems to be sufficient o induce a retro-con- 
trol on the activity of MAPKK. 
As a final point, we examined whether expression of 
the T292/386A mutant, which displays enhanced activity 
in response to mitogens, reduces the requirement for 
growth factors to stimulate cell proliferation. This was 
shown not to be the case (data not shown). However, this 
aspect deserves further investigation, in particular by 
combining mutations that constitutively activate 
MAPKK [11] together with the T292/386A mutation. 
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Note added in proof 
During the completion of this work, Saito et al. [FEBS Letters (1994) 341, 119] identified identical phosphorylation 
sites on MAP kinase kinase of PC12 cells following MAP kinase activation in response to NGF. 
